FDA product code PZR: Percutaneous Nerve Stimulator For Opioid Withdrawal
PZR is the FDA product code for percutaneous nerve stimulator for opioid withdrawal. It is a Class II device, regulated under 21 CFR 882.5896 and reviewed by the Neurology panel. FDA has cleared 7 510(k) submissions under PZR, 4 in the last five years, from 3 different applicants. The average 510(k) review took 135 days (median 133); 185 days on average over the last three years. 1 De Novo request was granted under it. FDA has posted 1 recall for PZR devices, 1 initiated in the last five years.
Definition
Stimulate nerve branches to aid in the reduction of symptoms associated with substance use disorders.
Classification
| Field | Value |
|---|---|
| Device name | Percutaneous Nerve Stimulator For Opioid Withdrawal |
| Device class | Class II |
| Regulation | 21 CFR 882.5896 |
| Review panel | NE — Neurology |
| Medical specialty | Neurology |
| Premarket route | 510(k) |
510(k) clearances per year for PZR
| Year | Clearances | Avg. review days |
|---|---|---|
| 2018 | 1 | 133 |
| 2021 | 2 | 156 |
| 2022 | 1 | 38 |
| 2023 | 1 | 90 |
| 2024 | 1 | 245 |
| 2025 | 1 | 125 |
Compare with all 510(k) review times · Search every PZR clearance
Top PZR applicants
| Applicant | Clearances | Latest |
|---|---|---|
| Spark Biomedical, Inc. | 3 | 2025-08-25 |
| Dyansys, Inc. | 3 | 2022-06-06 |
| Net Recovery | 1 | 2024-05-29 |
Most recent PZR clearances
| 510(k) | Applicant | Device | Decision date | Review days |
|---|---|---|---|---|
| K251246 | Spark Biomedical, Inc. | Sparrow Ascent | 2025-08-25 | 125 |
| K233166 | Net Recovery | NET Recovery Corp/NET Device | 2024-05-29 | 245 |
| K230796 | Spark Biomedical, Inc. | Sparrow Ascent | 2023-06-20 | 90 |
| K221231 | Dyansys, Inc. | Drug Relief v1 | 2022-06-06 | 38 |
| K211971 | Dyansys, Inc. | Drug Relief v1 | 2021-11-05 | 134 |
Recalls for PZR devices
1 product recalls in 1 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2025-07-02.
| Year | Recalls |
|---|---|
| 2025 | 1 |
Frequently asked questions
What is FDA product code PZR?
PZR is the FDA product code for percutaneous nerve stimulator for opioid withdrawal. It is a Class II device, regulated under 21 CFR 882.5896 and reviewed by the Neurology panel.
What device class is PZR?
Class II, regulation 21 CFR 882.5896. Typical premarket route: 510(k).
How long does a 510(k) take for product code PZR?
Across 7 cleared submissions the average was 135 days from receipt to decision (median 133).
Which companies have the most PZR clearances?
Spark Biomedical, Inc. (3); Dyansys, Inc. (3); Net Recovery (1).
Have PZR devices been recalled?
Yes: 1 product recalls across 1 recall events; the most recent began 2025-07-02.
Next steps
- Run an FDA pathway report with predicate devices for product code PZR
- Run a recall and safety report across every PZR manufacturer
- Watch product code PZR for new clearances and recalls
Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.
All Neurology product codes · FDA product code lookup · 510(k) database search · 510(k) review times